Cangrelor: Fixing Life or Just a Leak?

JACC: Cardiovascular Interventions

Volumn 9, Issue 18, 2016, Pages 1914-1916

  Kerneis, Mathieu ^a   Silvain, Johanne ^a   Montalescot, Gilles ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

antiplatelet drug; P2Y12 antagonist; stable coronary artery disease

Indexed keywords

CANGRELOR; CLOPIDOGREL; ADENOSINE PHOSPHATE; ANTITHROMBOCYTIC AGENT; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; EDITORIAL; HUMAN; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADENOSINE MONOPHOSPHATE; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TICLOPIDINE;

EID: 84989204350     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.07.025     Document Type: Editorial

References (15)

1. 1 Bhatt, D.L., Stone, G.W., Mahaffey, K.W., et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 368 (2013), 1303–1313.
2. 2 Abtan, J., Steg, P.G., Stone, G.W., et al. Efficacy and safety of cangrelor in preventing periprocedural complications in patients with stable angina and acute coronary syndromes undergoing percutaneous coronary intervention: the CHAMPION PHOENIX trial. J Am Coll Cardiol Intv 9 (2016), 1905–1913.
3. 3 Thygesen, K., Alpert, J.S., White, H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007), 2173–2195.
4. 4 Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
5. 5 Baker, N.C., Lipinski, M.J., Escarcega, R.O., et al. Definitions of periprocedural myocardial infarction as surrogates for catheterization laboratory quality or clinical trial end points. Am J Cardiol 113 (2014), 1326–1330.
6. 6 Nienhuis, M.B., Ottervanger, J.P., Bilo, H.J.G., Dikkeschei, B.D., Zijlstra, F., Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 71 (2008), 318–324.
7. 7 Miller, W.L., Garratt, K.N., Burritt, M.F., Lennon, R.J., Reeder, G.S., Jaffe, A.S., Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 27 (2006), 1061–1069.
8. 8 Wiviott, S.D., Braunwald, E., McCabe, C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007), 2001–2015.
9. 9 Cannon, C.P., Harrington, R.A., James, S., et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 375 (2010), 283–293.
10. 10 Park, D.-W., Kim, Y.-H., Yun, S.-C., et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J 34 (2013), 1662–1669.
11. 11 Mehran, R., Pocock, S., Nikolsky, E., et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. J Am Coll Cardiol Intv 4 (2011), 654–664.
12. 12 Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
13. 13 Kwok, C.S., Rao, S.V., Myint, P.K., et al. Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart, 1, 2014, e000021.
14. 14 Christensen, M.K., Huang, H., Torp-Pedersen, C., Trydal, T., Ravkilde, J., Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study. BMC Cardiovasc Disord, 16, 2016, 140.
15. 15 Guerra, E., Ndrepepa, G., Schulz, S., et al. Impact of in-hospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention. Am Heart J 168 (2014), 862–868.e1.